Spots Global Cancer Trial Database for antiangiogenic
Every month we try and update this database with for antiangiogenic cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours | NCT02042781 | Advanced Solid ... | PG545 | 18 Years - | Zucero Pty Ltd | |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | NCT04527068 | Refractory Meta... pMMR MSS | Bevacizumab Tripleitriumab | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer | NCT00357500 | Central Nervous... Leukemia Lymphoma Neuroblastoma Sarcoma Unspecified Chi... | celecoxib cyclophosphamid... etoposide fenofibrate thalidomide | - 21 Years | Dana-Farber Cancer Institute | |
| Surufatinib Combined With Carboplatin/Paclitaxel and Surufatinib Combined With Olaparib as First-line and Maintenance Therapy for Newly Diagnosed High-risk Ovarian Cancer | NCT06437353 | Ovarian Cancer | Paclitaxel | 18 Years - 75 Years | Anhui Provincial Cancer Hospital | |
| A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma | NCT00352742 | Multiple Myelom... | ATN-224 + borte... | 18 Years - | Attenuon | |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | NCT04527068 | Refractory Meta... pMMR MSS | Bevacizumab Tripleitriumab | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Study of the Safety and Tolerability of IV Infused PG545 in Patients With Advanced Solid Tumours | NCT02042781 | Advanced Solid ... | PG545 | 18 Years - | Zucero Pty Ltd | |
| A Study of ATN-224 and Bortezomib in Patients With Multiple Myeloma | NCT00352742 | Multiple Myelom... | ATN-224 + borte... | 18 Years - | Attenuon | |
| Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma | NCT00722865 | Hodgkin Lymphom... | Avastin | 18 Years - | Massachusetts General Hospital | |
| A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer | NCT00356681 | Breast Neoplasm... Breast Tumors Breast Cancer Locally Recurre... | AMG 706 placebo Bevacizumab AMG 706 Paclitaxel | 18 Years - | Amgen | |
| Vascular Dysfunction and Antiangiogenic Therapy | NCT02161978 | Solid Tumor Tumor Angiogene... Endothelial Dys... CML (Chronic My... | 18 Years - | University Hospital, Angers | ||
| Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | NCT01356290 | Medulloblastoma... Ependymoma Recu... ATRT Recurrent | Bevacizumab Thalidomide Celecoxib Fenofibric acid Etoposide Cyclophosphamid... Etoposide phosp... Cytarabine | - 19 Years | Medical University of Vienna | |
| QL1101 in Combination With JS001 in Patients With pMMR/MSS Refractory Metastatic Colorectal Cancer | NCT04527068 | Refractory Meta... pMMR MSS | Bevacizumab Tripleitriumab | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma and ATRT | NCT01356290 | Medulloblastoma... Ependymoma Recu... ATRT Recurrent | Bevacizumab Thalidomide Celecoxib Fenofibric acid Etoposide Cyclophosphamid... Etoposide phosp... Cytarabine | - 19 Years | Medical University of Vienna | |
| A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer | NCT00356681 | Breast Neoplasm... Breast Tumors Breast Cancer Locally Recurre... | AMG 706 placebo Bevacizumab AMG 706 Paclitaxel | 18 Years - | Amgen |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
